Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension
Shots: Klaria to receive $55.2M as total deal value, including $5.2M as near-term milestones and royalties on sales from Purdue. Purdue to get exclusive license rights to develop & commercialize Klaria’s KL-01401 Klaria will take care the manufacture and supply of KL-01401 developed using its own drug delivery technology and has granted it patent rights […]Read More
